Rie Takahashi, MD
Dermatology · Springfield, ORNPI 1528476322
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,950 of the $8,927 with a category attached, or 66.7%. Regeneron accounts for 68.3% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $7,092, more than ten times the $144 reported in 2022.
Across 123 payments — averaging $72.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$6K
- AbbVie$577
- Johnson & Johnson$427
- Regeneron Healthcare Solutions, Inc.$308
- UCB, Inc.$289
- E.r. Squibb & Sons, L.L.C.$272
- plus $959 from 12 others
What the payments were for
- Consulting fees$5,95067%
- Food & beverage$2,79631%
- Education$1802%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $6,095 |
| AbbVie | 39 | $577 |
| Johnson & Johnson | 20 | $427 |
| Regeneron Healthcare Solutions, Inc. | 6 | $308 |
| UCB, Inc. | 9 | $289 |
| E.r. Squibb & Sons, L.L.C. | 10 | $272 |
| Novartis | 10 | $221 |
| Sanofi | 7 | $189 |
| Sun Pharmaceutical Industries Inc. | 3 | $143 |
| Pfizer | 4 | $76 |
| LEO Pharma Inc. | 3 | $63 |
| Mallinckrodt Hospital Products Inc. | 2 | $62 |
| Smith+Nephew | 1 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Organon | 1 | $28 |
| Incyte Corporation | 1 | $22 |
| Biofrontera Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$6,095
How this compares
$8,927 in reported general payments places this provider in the 85th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 124 | $1,158 |
| Cephalexin | 146 | $718 |
| Doxycycline Hyclate | 46 | $437 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $57 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Springfield
- Eric OlsonSpringfield$4K
- Natalie KudlakSpringfield$4K
- Samuel BalinSpringfield$3K
- Jordan CookSpringfield$3K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.